Patents
The chimeric protein immunogen manufacturing technology, which is the core technology of foot-and-mouth disease recombinant protein vaccine with excellent immunogenic capabilities using our platform technology of protein engineering, has been registered for a patent in 13 countries worldwide including Korea.
Patent Registration Status
Country | Patent Number | Designation | Registration Date | State |
---|---|---|---|---|
EU(EP) | 09821602.1 |
A vaccine composition against foot-and-mouth disease and the preparation method thereof |
2017-03-03 | Enrollment |
Vietnam | 15506 |
A vaccine composition against foot-and-mouth disease and the preparation method thereof |
2016-05-16 | Enrollment |
Philippines | 1-2011-500792 |
A vaccine composition against foot-and-mouth disease and the preparation method thereof |
2016-01-14 | Enrollment |
Canada | 2741419 |
Anti-FMD vaccine composition and the preparation and use thereof |
2015-01-27 | Enrollment |
Hong Kong | HK1144787 |
Anti-FMD Vaccine Composition and Preparation and Use Thereof |
2014-11-14 | Enrollment |
Japan | 5565877 |
Anti-FMD vaccine composition and preparation and use thereof |
2014-06-27 | Enrollment |
USA | 8,551,495 |
ANTI-FMD VACCINE COMPOSITION AND THE PREPARATION AND USE THEREOF |
2013-10-08 | Enrollment |
Republic of Korea | 10-1313159 |
Foot and mouth disease vaccine composition and preparation method thereof |
2013-09-24 | Enrollment |
Australia | 2009306900 |
A vaccine composition against foot-and-mouth disease and the preparation method thereof |
2013-09-19 | Enrollment |
AU-2009306900
CN-ZL200810172927
EP-2351581
JP-5565877
PH_1-2011-500792
Turkey_PAT
US-8,551,495
VN_15506
New Excellent Technology Certificate
The foot-and-mouth disease recombinant protein vaccine technology of Pharos Vaccine has obtained New Excellent Technology (NET) certificate from the Ministry of Trade, Industry and Energy and Ministry of Agriculture, Food and Rural Affairs after thorough verification procedures by the Korean government.
Certification | Certification Number | Technical Name | Certification Date |
---|---|---|---|
Ministry of Agriculture, Food and Rural Affairs | No. 23-057 |
Recombinant protein and foot-and-mouth disease bivalent composition manufacturing technology |
2018-07-05 |
Ministry of Trade, Industry and Energy | No. 0948 |
Manufacturing technology of foot and mouth vaccine composition using VP1 repeat recombinant protein |
2015-08-27 |
NET New Technology Certificate Ministry of Agriculture and Food (Korean)
NET New Technology Certificate Ministry of Agriculture and Food (English)
ANIMAL MEDICINE APPROVAL
Pharos Vaccine’s foot-and-mouth disease recombinant protein vaccine PharoVax-FMD has been validated for its safety and efficacy with a field clinical trial and virus challenge test, and is the first to obtain an animal medicine approval for foot-and-mouth disease vaccine in Korea. This is the first approval in the world of an FMD vaccine using recombinant protein as the immunogen, and Pharos Vaccine is not only promoting the product domestically, but is also exporting our FMD vaccine technology and products to foreign countries including China and Vietnam based on our excellent technology.
PharoVax-FMD approval certificate